Hospital News and Research

RSS

Sedation interruption does not reduce mechanical ventilation duration

Daily sedative interruption of mechanically ventilated patients in intensive care units does not reduce the time they are on ventilation or improve their clinical outcomes, report researchers in JAMA.

29 Oct 2012

Experts explore decline in throat infection admissions

Hospital admissions for acute throat infection in children have increased significantly over the past decade in the UK, while the rate of tonsillectomy has declined, researchers report.

29 Oct 2012

Positive interim data from XBiotech monoclonal antibody Phase II study for type 2 diabetes

XBiotech, a privately held biotechnology company, announced positive interim analysis results today from a Phase II study using a True Human monoclonal antibody (MABp1) in patients with type 2 diabetes. Results from this study continue to reinforce the role of IL-1α as a master regulator of chronic inflammation in multiple disease states, and the therapeutic benefits of neutralizing antibodies produced from the XBiotech platform.

29 Oct 2012

Scientists decode epigenetic programming of three virulent forms of acute lymphoblastic leukemia

A team of national and international researchers, led by Weill Cornell Medical College scientists, have decoded the key "software" instructions that drive three of the most virulent forms of acute lymphoblastic leukemia (ALL). They discovered ALL's "software" is encoded with epigenetic marks, chemical modifications of DNA and surrounding proteins, allowing the research team to identify new potential biomarkers and therapeutic targets.

29 Oct 2012

AstraZeneca commences FASLODEX Phase III study for hormone receptor-positive metastatic breast cancer

AstraZeneca today announced the start of a Phase III study (FALCON), a global clinical trial which will involve 450 postmenopausal patients with hormone receptor-positive locally advanced or metastatic breast cancer who have not previously been treated with any hormonal therapy. The Phase III study is designed to evaluate the efficacy and tolerability of fulvestrant 500 mg compared to anastrozole 1 mg in this patient population.

29 Oct 2012

Insurers, hospital stocks register presidential election jitters

As polls show a virtual tie between President Barack Obama and GOP challenger Mitt Romney, news outlets report on how the health care industry and those who are sick or uninsured are contemplating the possible outcomes.

29 Oct 2012

Cellectis announces successful programming of immune system cells to kill cancer cells

Cellectis, the genome engineering specialist, has announced successfully programming cells from the immune system (T cells) to kill cancer cells. This technological breakthrough was revealed for the first time ever on Saturday, October 27th at the congress of the ESGCT (European Society of Gene & Cell Therapy) in Versailles, outside Paris.

29 Oct 2012

The App That's Transforming Blood Banking

An interview with Celia Tombalankian, discussing the benefits of automation in blood banking and the development of a new blood banking app.

From Ortho-Clinical Diagnostics, Inc. 29 Oct 2012

Baylor Institute for Rehabilitation receives $2.2 million grant

Baylor Institute for Rehabilitation (BIR) has received a $2.2 million grant extending for another five years the institute's designation as a National Institute on Disability and Rehabilitation Research Model System site for traumatic brain injury.

29 Oct 2012

Improvements in rare cell isolation and common blood tests

At the Sixteenth International Conference on Miniaturized Systems for Chemistry and Life Sciences (microTAS) to be held Oct. 28-Nov. 1, in Okinawa, Japan, University of Cincinnati researchers will present four papers, including one detailing improvements in rare cell isolation and one detailing improvements, in terms of cost and time, of common blood tests.

29 Oct 2012

HHS fraud squad digging into allegations of EHR overbilling

The fraud squad of the US Department of Health and Human Services (HHS) has mailed out a 54-question survey that digs into widespread allegations of Medicare overbilling committed with electronic health records (EHRs).

29 Oct 2012

Researchers learn how E2-79 molecule destroys complexes that induce allergic responses

Researchers have learned how a man-made molecule destroys complexes that induce allergic responses - a discovery that could lead to the development of highly potent, rapidly acting interventions for a host of acute allergic reactions.

29 Oct 2012

Haemonetics second quarter 2013 net revenue increases 22% to $218.2 million

Haemonetics Corporation today reported second quarter 2013 net revenue of $218.2 million, up 22%, GAAP net income of $6.5 million, down 53%, and diluted earnings per share of $0.25, down 53%.

29 Oct 2012

New therapy to treat rare form of cystic fibrosis works in unconventional way, scientists say

Scientists at the Hospital for Sick Children in Toronto have established that a drug recently approved by the U.S. Food and Drug Administration to treat a rare form of cystic fibrosis works in an unconventional way.

29 Oct 2012

Researchers identify genes linked to serous endometrial cancer

Researchers have identified several genes that are linked to one of the most lethal forms of uterine cancer, serous endometrial cancer.

29 Oct 2012

Neuraxial anesthesia should be promoted for bilateral total knee replacements: HSS

Using regional anesthesia rather than general anesthesia reduces the need for blood transfusions in patients undergoing bilateral total knee replacement, according to a new study by researchers at Hospital for Special Surgery, in New York City.

29 Oct 2012

Research team receives grant to study impact of urban air pollution on TB immunity

An international team of researchers, led by Stephan Schwander, MD, PhD, director of the Center for Global Public Health at the University of Medicine and Dentistry of New Jersey-School of Public Health, has received a $2.96 million grant to conduct a "real-world" study on the impact of urban air pollution on the human immune system's ability to resist Mycobacterium tuberculosis, the bacterium that causes tuberculosis.

29 Oct 2012

Researchers use baker's yeast to identify new therapies for Lou Gehrig's disease

Amyotrophic lateral sclerosis, also called Lou Gehrig's disease, is a devastatingly cruel neurodegenerative disorder that robs sufferers of the ability to move, speak and, finally, breathe.

29 Oct 2012

New HIV test for babies differs from conventional test, delivers diagnosis in less than an hour

Today, mothers in Africa sometimes walk more than 10 miles to a clinic only to learn that conventional HIV test results for their babies are not available yet.

29 Oct 2012

St. Luke's cardiologist wins TCT 2012 Geoffrey O. Hartzler Master Clinical Operator Award

Barry D. Rutherford, MD, a world renowned interventional cardiologist, was presented the TCT 2012 Geoffrey O. Hartzler Master Clinical Operator Award in a ceremony held today during the 24th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF).

29 Oct 2012

Hospital News and Research

Sedation interruption does not reduce mechanical ventilation duration

Experts explore decline in throat infection admissions

Positive interim data from XBiotech monoclonal antibody Phase II study for type 2 diabetes

Scientists decode epigenetic programming of three virulent forms of acute lymphoblastic leukemia

AstraZeneca commences FASLODEX Phase III study for hormone receptor-positive metastatic breast cancer

Insurers, hospital stocks register presidential election jitters

Cellectis announces successful programming of immune system cells to kill cancer cells

The App That's Transforming Blood Banking

Baylor Institute for Rehabilitation receives $2.2 million grant

Improvements in rare cell isolation and common blood tests

HHS fraud squad digging into allegations of EHR overbilling

Researchers learn how E2-79 molecule destroys complexes that induce allergic responses

Haemonetics second quarter 2013 net revenue increases 22% to $218.2 million

New therapy to treat rare form of cystic fibrosis works in unconventional way, scientists say

Researchers identify genes linked to serous endometrial cancer

Neuraxial anesthesia should be promoted for bilateral total knee replacements: HSS

Research team receives grant to study impact of urban air pollution on TB immunity

Researchers use baker's yeast to identify new therapies for Lou Gehrig's disease

New HIV test for babies differs from conventional test, delivers diagnosis in less than an hour

St. Luke's cardiologist wins TCT 2012 Geoffrey O. Hartzler Master Clinical Operator Award

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News